References
Alavi A, Basu S. Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time? Eur J Nucl Med Mol Imaging. 2008.
Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med. 2006;36:228–47.
Ravina B, Eidelberg D, Ahlskog JE, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 2005;64:208–15.
Seibyl JP, Chen W, Silverman DH. 3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine positron emission tomography in patients with central motor disorders and in evaluation of brain and other tumors. Semin Nucl Med. 2007;37(6):440–50. Nov.
Kowalski J, Henze M, Schuhmacher J, Macke HR, Hofmann M, Haberkorn U. Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe1-Tyr3-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol. 2003;5:42–8.
Watson E, Stabin M, Stubbs J. Dosimetry of technetium-94m-teboroxime. J Nucl Med. 1994;35:923–4.
Pentlow KS, et al. Quantitative imaging of Iodine-124 PET. J Nucl Med. 1996;37:1557–62.
Lubberink M, van Schie A, de Jong HWAM, van Dongen GAMS, Teule GJJ. Acquisition settings for PET of 124I dministered simultaneously with therapeutic amounts of 131I. J Nucl Med. 2006;47:1375–81.
Finn R. Chemistry applied to iodine radionuclides. Handbook of radiopharmaceuticals. Chichester: Wiley; 2003. p. 423–5.
Rault E, Vandenberghe S, Van Holen R, De Beenhouwer J, Staelens S, Lemahieu I. Comparison of image quality of different iodine isotopes (I-123, I-124, and I-131). Cancer Biother Radiopharm. 2007;22:423–30.
Brambilla M, Matheoud R, Secco C, Sacchetti G, Comi S, Rudoni M, et al. Impact of target-to-background ratio, target size, emission scan duration, and activity on physical figures of merit for a 3D LSO-based whole body PET/CT scanner. Med Phys 2007;34:3854–65.
Vandenberghe S. Three-dimensional positron emission tomography imaging with 124I and 86Y. Nucl Med Commun. 2006;27:237–45.
Pentlow KS, Graham MC, Lambrecht RM, Cheung N-KV, Larson SM. Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy. Med Phys. 1991;18:357–66.
Pentlow KS, Finn RD, Larson SM, Erdi YE, Beattie BJ, Humm JL. Quantitative imaging of Yttrium-86 with PET—the occurrence and correction of anomalous apparent activity in high density regione. Clin Positron Imaging. 2000;3:85–90.
Walrand S, Jamar F, Mathieu I, De Camps J, Lonneux M, Sibomana M, et al. Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86. Eur J Nucl Med. 2003;30:354–61.
Herzog H, Tellmann L, Scholten B, Coenen HH, Qaim SM. PET imaging problems with the non-standard positron emitters Yttrium-86 and Iodine-124. Q J Nucl Med Mol Imaging. 2007;52:159–65.
Taylor A Jr, Nally JV. Clinical applications of renal scintigraphy. AJR Am J Roentgenol. 1995;164:31–41.
Unver T, Alpay H, Biyikli NK, Ones T. Comparison of direct radionuclide cystography and voiding cystourethrography in detecting vesicoureteral reflux. Pediatr Int. 2006;48:287–91. Jun.
Mariani G, Boni G, Barreca M, Bellini M, Fattori B, AlSharif A, et al. Radionuclide gastro-esophageal motor studies. J Nucl Med. 2004;45:1004–28.
Mariani G, Pauwels EKJ, AlSharif A, Marchi S, Boni G, Barreca M, Bellini M, et al. Radionuclide evaluation of the lower gastrointestinal tract. J Nucl Med. 2008;49:776–87.
Katsuhiro U. Clinical evaluation of hepatobiliary scintigraphy. Japan J Med Imaging. 1999;18:111–22.
Shah KK, Shah KK, Fink-Bennett D, Kumar KG, McCaughey RS. Extrahepatic biliary obstruction versus intrahepatic disorder. Differentiation with hepatobiliary scintigraphy and ultrasonography. J Clin Gastroenterol. 1988;10:191–6.
Connolly LP, Treves ST, Bozorgi F, O’Connor SC. Meckel’s diverticulum: demonstration of heterotopic gastric mucosa with technetium-99m-pertechnetate SPECT. J Nucl Med. 1998;39:1458–60.
Schillaci O, Filippi L, Danieli R, Simonetti G. Single-photon emission computed tomography/computed tomography in abdominal diseases. Semin Nucl Med. 2007;37:48–61.
Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology. 1988;167:729–35.
Vaqueiro M, Gloviczki P, Fisher J, Hollier LH, A Schirger A, Wahner HW. Lymphoscintigraphy in lymphedema: an aid to microsurgery. J Nucl Med. 1986;27:1125–30.
Mariani G, Moresco L, Viale G, Villa G, Bagnasco M, Canavese G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001;42:1198–15.
Mariani G, Gipponi M, Moresco L, Villa G, Bartolomei M, Mazzarol G, et al. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med. 2002;43:811–27.
Mariani G, Giuliano AE, Strauss HW. Radioguided surgery: a comprehensive team approach. New York, NY: Springer; 2008.
Bajc M, Albrechtsson U, Olsson C-G, Olsson B, Jonson B. Comparison of ventilation/perfusion scintigraphy and helical CT for diagnosis of pulmonary embolism; strategy using clinical data and ancillary findings. Clin Physiol Funct Imaging. 2002;22:392–7.
Stein PD, Woodard PK, Weg JG, Wakefield TW, Tapson VF, Sostman HD, et al. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Radiology. 2007;242:15–21.
Forstrom LA, Mullan BP, Hung JC, Lowe VJ, Thorson LM. 18F-FDG labelling of human leukocytes. Nucl Med Commun. 2000;21:691–4.
Osman S, Danpure HJ. The use of 2-[18F]-fluoro-2-deoxy-d-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B. 1992;19:183–90.
Guhlmann A, Brecht-Krauss D, Suger G, Glatting G, Kotzerke J, Kinzl L, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology. 1998;206:749–54.
Stumpe KDM, Zanetti M, Weishaupt D, Hodler J, Boos N, von Schulthess GK. FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. AJR Am J Roentgenol. 2002;179:1151–7.
Gratz S, Dorner J, Fischer U, Behr TM, Behe M, Altenvoerde G, Meller J, et al. 18F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med Mol Imaging. 2002;29:516–24.
De Winter F, Gemmel F, Van de Wiele C, Poffijn B, Uyttendaele D, Dierckx R. 18-Fluorine fluorodeoxyglucose positron emission tomography for the diagnosis of infection in the postoperative spine. Spine. 2003;28:1314–9.
O’Connor MK, Kemp BJ. Single-photon emission computed tomography/computed tomography: basic instrumentation and innovations. Semin Nucl Med. 2006;36:258–66.
Beekman F, Hutton B. Multi-modality imaging on track. Eur J Nucl Med Mol Imaging. 2007;34:1410–4.
Husarik DB, Steinert HC. Single-photon emission computed tomography/computed tomography for sentinel node mapping in breast cancer. Semin Nucl Med. 2007;37:29–33.
Krausz Y, Israel O. Single-photon emission computed tomography/computed tomography in endocrinology. Semin Nucl Med. 2006;36:267–74.
Schillaci O. Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma. Semin Nucl Med. 2006;36:275–85.
Horger M, Bares R. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease. Semin Nucl Med. 2006;36:286–94.
Bunyaviroch T, Aggarwal A, Oates ME. Optimized scintigraphic evaluation of infection and inflammation: role of single-photon emission computed tomography/computed tomography fusion imaging. Semin Nucl Med. 2006;36:295–311.
Sodee DB, Sodee AE, Bakale G. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer. Semin Nucl Med. 2007;37:17–28.
Schillaci O, Filippi L, Manni C, Santoni R. Single-photon emission computed tomography/computed tomography in brain tumors. Semin Nucl Med. 2007;37:34–47.
Lee ST, Scott AM. Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole. Semin Nucl Med. 2007;37:451–61.
Kelly CJ, Brady M. A model to simulate tumour oxygenation and dynamic [18F]-Fmiso PET data. Phys Med Biol. 2006;51:5859–73.
Padhani AR, Krohn KA, Lewis JS, Alber M. Imaging oxygenation of human tumours. Eur Radiol. 2007;17:861–72.
Halley A, Hugentobler A, Icard P, Porret E, Sobrio F, Lerochais JP, et al. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging. 2005;32:1026–32.
Rodrigues M, Li S, Gabriel M, Heute D, Greifeneder M, Virgolini I. 99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer. J Clin Endocrinol Metab. 2006;91:3997–4000.
Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med 2003;44:1443–58.
Rahmim A, Zaidi H. PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun. 2008;29:193–207.
Author information
Authors and Affiliations
Corresponding author
Additional information
The opinions expressed within the Controversies section represent the views of the authors only. The article arguing for this proposition is published at http://dx.doi.org/10.1007/s00259-008-0813-2
Rights and permissions
About this article
Cite this article
Mariani, G., Bruselli, L. & Duatti, A. Is PET always an advantage versus planar and SPECT imaging?. Eur J Nucl Med Mol Imaging 35, 1560–1565 (2008). https://doi.org/10.1007/s00259-008-0814-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-008-0814-1